share_log

6-K: Gsk Today Announced Positive Results from the Pivotal Eagle-1 Phase Iii Trial for Gepotidacin

SEC announcement ·  Apr 17 06:09
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more